Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19.

M, Fragiel; Ò, Miró; P, Llorens; S, Jiménez; P, Piñera; G, Burillo; A, Martín; FJ, Martín-Sánchez; EJ, García-Lamberechts; J, Jacob; A, Alquézar-Arbé; R, Juárez; B, Jiménez; Rio R, Del; Roca M, Mateo; AH, García; Laguna N, López; Diez MP, Lopez; García J, Pedraza; de Simón Almela A, Fernández; Diaz JJ, Lopez; Hernández P, Eiroa; de Lobera N, Ruiz; J, Porta-Etessam; Pérez C, Fernández; E, Calvo; Del Castillo J, González

doi:10.1002/ana.25987

Public

Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19.

Shared by NobleBlocks on Dec 28, 2020 • 12:00 AM UTC

Authors:

Fragiel M

Miró Ò

Llorens P

Abstract

We diagnosed 11 Guillain-Barré syndrome (GBS) cases among 71,904 COVID patients attended at 61 Spanish emergency departments (EDs) during the 2-month pandemic peak. The relative frequency of GBS among ED patients was higher in COVID (0.15‰) than non-COVID (0.02‰) patients (odds ratio [OR] = 6.30, 95...

Discussions